Terje Espevik

37.6k citations

316 papers · 29.2k indexed · 10 hit papers · h-index 84

Impact in

Immunology top 0.02%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Atherosclerosis and Cardiovascular Diseases
Microbiology top 0.1%

Papers in

Immunology 219
- Immune Response and Inflammation 145
- Immune Cell Function and Interaction 45
- Complement system in diseases 35
- Immunotherapy and Immune Responses 21
Microbiology 26
- Antimicrobial Peptides and Activities 18

Co-authors: Anders Waage Egil Lien Eicke Latz Alfred Halstensen Douglas T. Golenbock Anders Sundan Gudmund Skjåk‐Bræk Katherine A. Fitzgerald
Journals: The Journal of Immunology (32 papers)Scandinavian Journal of Immunology (15 papers)Journal of Biological Chemistry (14 papers)The Journal of Experimental Medicine (10 papers)Molecular Immunology (9 papers)
Partner nations: Norway United States United Kingdom

In The Last Decade

Terje Espevik

310 papers receiving 28.5k citations

Hit Papers

10 papers align trajectories log scale

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial 2016 · 288 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 European Heart Journal
2013 Cardiovascular Research
2010 Nature
2004 Nature Immunology
2002 The Journal of Immunology
1999 Journal of Biological Chemistry
1992 The Journal of Experimental Medicine
1989 The Journal of Experimental Medicine
1987 The Lancet
1986 Journal of Immunological Methods

Peers

Countries citing papers authored by Terje Espevik

Since Specialization

Citations

This map shows the geographic impact of Terje Espevik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terje Espevik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terje Espevik more than expected).

Fields of papers citing papers by Terje Espevik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terje Espevik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terje Espevik. The network helps show where Terje Espevik may publish in the future.

Co-authors

The 25 scholars most cited alongside Terje Espevik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Terje Espevik Line = papers co-authored together Terje Espevik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The role of intracellular and cell-autonomous C3 in NF-κB priming in human macrophages Immunobiology ·Charlotte Årseth, Stine Kristensen, Harald Husebye, Terje Espevik, Liv Ryan, Tom Eirik Mollnes, John D. Lambris, Trude Helen Flo	2025	0
2	The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation Frontiers in Immunology ·Beatrice Fageräng, Leon Cyranka, Camilla Schjalm, Karin Ekholt McAdam, Carina Sandem Larsen, Julia Heinzelbecker, Tobias Gedde‐Dahl, Reinhard Würzner, Terje Espevik, Geir E. Tjønnfjord, Peter Garred, Andreas Barratt‐Due, Tor Henrik Anderson Tvedt, Tom Eirik Mollnes	2024	2
3	Thrombin Differentially Modulates the Acute Inflammatory Response to Escherichia coli and Staphylococcus aureus in Human Whole Blood The Journal of Immunology ·Chris A. Johnson, Huy Quang Quach, Corinna Lau, Karin Ekholt, Terje Espevik, Trent M. Woodruff, Søren Erik Pischke, Tom Eirik Mollnes, Per H. Nilsson	2022	2
4	Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood The Journal of Immunology ·Anub Mathew Thomas, Alexandra Gerogianni, Martin B. McAdam, Yngvar Fløisand, Corinna Lau, Terje Espevik, Per H. Nilsson, Tom Eirik Mollnes, Andreas Barratt‐Due	2019	32
5	The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2 PLoS Pathogens ·Astrid Skjesol, Maria Yurchenko, Korbinian Bösl, Caroline Gravastrand, Kaja Elisabeth Nilsen, Lene Melsæther Grøvdal, Federica Agliano, Francesco Patanè, Germana Lentini, Hera Kim, Giuseppe Teti, Aditya Kumar Sharma, Richard K. Kandasamy, Bjørnar Sporsheim, Kristian K. Starheim, Douglas T. Golenbock, Harald Stenmark, Mary McCaffrey, Terje Espevik, Harald Husebye	2019	38
6	NHDL, a recombinant V _L /V _H hybrid antibody control for IgG2/4 antibodies mAbs ·Corinna Lau, Martin B. McAdam, Grethe Bergseth, Algirdas Grevys, Jack‐Ansgar Bruun, Judith Krey Ludviksen, Hilde Fure, Terje Espevik, Anders Moen, Jan Terje Andersen, Tom Eirik Mollnes	2019	3
7	Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor The Journal of Immunology ·Caroline Gravastrand, Bjørg Steinkjer, Bente Halvorsen, Anne Landsem, Mona Skjelland, Eva Astrid Jacobsen, Trent M. Woodruff, John D. Lambris, Tom Eirik Mollnes, Ole‐Lars Brekke, Terje Espevik, Anne Mari Rokstad	2019	27
8	Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14 Molecular Immunology ·Espen Waage Skjeflo, Dorte Christiansen, Anne Landsem, Jørgen Stenvik, Trent M. Woodruff, Terje Espevik, Erik Waage Nielsen, Tom Eirik Mollnes	2019	8
9	Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction International Journal of Cardiology ·Ola Kleveland, Thor Ueland, Gabor Kunszt, Marte Bratlie, Arne Yndestad, Kaspar Broch, Espen Holte, Liv Ryan, Brage H. Amundsen, Bjørn Bendz, Svend Aakhus, Terje Espevik, Bente Halvorsen, Tom Eirik Mollnes, Rune Wiseth, Lars Gullestad, Pål Aukrust, Jan Kristian Damås	2018	27
10	Cyclodextrin Reduces Cholesterol Crystal–Induced Inflammation by Modulating Complement Activation The Journal of Immunology ·Siril S. Bakke, Marie Aune, Nathalie Niyonzima, Katrine Pilely, Liv Ryan, Mona Skjelland, Peter Garred, Pål Aukrust, Bente Halvorsen, Eicke Latz, Jan Kristian Damås, Tom Eirik Mollnes, Terje Espevik	2017	40
11	Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis The Journal of Immunology ·Katrine Pilely, Anne Rosbjerg, Ninette Genster, Péter Gál, Gábor Pál, Bente Halvorsen, Sverre Holm, Pål Aukrust, Siril S. Bakke, Bjørnar Sporsheim, Ingunn Nervik, Nathalie Niyonzima, Emil D. Bartels, Gregory L. Stahl, Tom Eirik Mollnes, Terje Espevik, Peter Garred	2016	34
12	Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood The Journal of Immunology ·Stig Nymo, Alice Gustavsen, Per H. Nilsson, Corinna Lau, Terje Espevik, Tom Eirik Mollnes	2016	15
13	P075 Epithelial Toll-like receptor 3-dependent synthesis of complement factor B and local complement activation in inflammatory bowel disease Journal of Crohn s and Colitis ·Ann Elisabet Østvik, Atle van Beelen Granlund, Björn Gustafsson, Sverre H. Torp, Terje Espevik, Jan Kristian Damås, Tom Eirik Mollnes, Anders Sandvik	2014	1
14	Transplantation of alginate microcapsules Transplantation ·Bård Kulseng, G Skrak-Braek, Louise Ryan, Anne Andersson, Agnes P. King, Arild Faxvaag, Terje Espevik	1999	26
15	Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. The Journal of Experimental Medicine ·Terje Espevik, Manfred Brockhaus, Hansruedi Loetscher, Unni Nonstad, Refaat Shalaby	1990	231
16	The involvement of human tumor necrosis factors- alpha and - beta in the mixed lymphocyte reaction. The Journal of Immunology ·M R Shalaby, Terje Espevik, Glenn C. Rice, A. J. Ammann, I S Figari, Gerald Ranges, Michael A. Palladino	1988	97
17	Transforming growth factor- beta 1 (TGF- beta 1) and recombinant human tumor necrosis factor- alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF- beta 1 and TGF- beta 2, and recombinant human TGF- beta 1. The Journal of Immunology ·Terje Espevik, I S Figari, Gerald Ranges, Michael A. Palladino	1988	147
18	Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. The Journal of Experimental Medicine ·Gerald Ranges, I S Figari, Terje Espevik, Michael A. Palladino	1987	422
19	Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. The Journal of Experimental Medicine ·Terje Espevik, Irene S. Figari, M R Shalaby, Gregory A. Lackides, Gail D. Lewis Phillips, H. Michael Shepard, Michael A. Palladino	1987	405
20	A freeze-etch study of dense fibres in rat spermatozoa Reproduction ·Terje Espevik, Arnljot Elgsaeter	1978	3

About Terje Espevik

Terje Espevik is a scholar working on Immunology, Microbiology, Immunology and Allergy, Virology and Hematology, having authored 316 papers that have together received 29.2k indexed citations. Recurring topics across this work include Immune Response and Inflammation (145 papers), Immune Cell Function and Interaction (45 papers), Complement system in diseases (35 papers), Immunotherapy and Immune Responses (21 papers), Inflammasome and immune disorders (20 papers), NF-κB Signaling Pathways (18 papers), Antimicrobial Peptides and Activities (18 papers) and Lipid Membrane Structure and Behavior (18 papers). The work is most often cited by research in Immunology (15.3k citations), Microbiology (1.8k citations), Virology (731 citations), Epidemiology (5.1k citations) and Immunology and Allergy (835 citations). Terje Espevik has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Anders Waage, Egil Lien, Eicke Latz, Alfred Halstensen, Douglas T. Golenbock, Anders Sundan, Gudmund Skjåk‐Bræk, Katherine A. Fitzgerald, Trude Helen Flo and P Brandtzæg. Their work appears in journals such as The Journal of Immunology, Scandinavian Journal of Immunology, Journal of Biological Chemistry, The Journal of Experimental Medicine and Molecular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact